A new clinical trial led by the Jaeb Center for Health Research has shown that automated insulin delivery (AID) systems can significantly improve blood sugar control in adults with type 2 diabetes who ...

Abbott, Dexcom, Insulet, Medtronic and others are developing next-gen sensors, pumps and algorithms for type 2 diabetes ...

The general mood among these heavyweight investors is divided, with 12% leaning bullish and 50% bearish. Among these notable ...

The "Diabetes Monitoring, Treatment and Drug Delivery Market Size, Share & Trends Analysis | United States | 2025-2031 | MedSuite | Includes: Insulin & GLP-1, Continuous Glucose Monitoring and 7 more" ...

DexCom receives a warning letter from the FDA citing several issues with its popular G6 & G7 sensor manufacturing. The ...

As per a clinical study, smartwatches can help drive meaningful exercise routines and lifestyle changes to help people ...

A study confirms Raman Spectroscopy’s potential for noninvasive glucose monitoring, improving calibration and accuracy.

Dexcom made a significant design change to a component used in its sensors and did not adequately validate the change, ...

SiBionics announced today that it unveiled its GS3 continuous glucose monitor (CGM), which now has CE mark approval.

A real-world analysis showed a link between continuous glucose monitor (CGM) distribution channel and outcomes for patients with diabetes.

CGMs are transforming health tracking for non-diabetics, providing insights into glucose levels and influencing dietary choices and athletic performance.

DexCom, Inc. DXCM recently unveiled new data for its upcoming G7 15-day continuous glucose monitoring (CGM) sensor at the Advanced Technologies & Treatments for Diabetes (ATTD) conference 2025. With ...